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Nuclear Reprogramming of Human Somatic Cells
by Xenopus Egg Extract Requires BRG1
manipulation of the reprogramming agent and allows
for cultivation of intact reprogrammed cells to eventually
establish undifferentiated cell lines. To this end, we have
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Deutsches Krebsforschungszentrum developed a mild and reversible permeabilization proto-
col with digitonin to deliver Xenopus egg extract toIm Neuenheimer Feld 280
D-69120 Heidelberg mammalian cells. Reversible cell permeabilization pro-
tocols have been used to reprogram somatic cells byGermany
exposure to cell extracts from T cells and neuronal cells,
which induced hematopoietic and neural specific genes,
respectively [7]. Such protocols were also recently ap-Summary
plied to identify a nucleolar disassembly activity in Xeno-
pus egg extract [8].Animal cloning by nuclear transplantation in amphibia
In dishes of human 293T kidney cells subjected towas demonstrated almost half a century ago [1] and
the reprogramming protocol (Figure 1A), spheroid cellraised the question of the mechanisms and genes in-
aggregates became visible at day 4 (Figures 1B–1D),volved in nuclear reprogramming. Here, we demon-
which formed even in the absence of egg extract andstrate nuclear reprogramming of permeabilized hu-
digitonin. 293T spheres were initially nonadherent andman cells using extracts from Xenopus laevis eggs and
grew rapidly. Spheres could be maintained as large ag-early embryos. We show upregulation of pluripotency
gregates for weeks, and some would eventually attach.markers Oct-4 and germ cell alkaline phosphatase
To test for nuclear reprogramming, mRNA expression(GCAP) in 293T cells and human primary leukocytes.
of Oct-4 and GCAP, which are pluripotency markers inReprogrammed leukocytes had a limited life span and
human and mouse [9–13], was analyzed by RT-PCRdid not express surface antigens characteristic of plur-
(Figure 1E). 293T cells express low levels of endogenousipotent cells, indicating that reprogramming was in-
Oct-4 and GCAP mRNAs, which are detectable by exten-complete. Reprogramming activity was detected in
sive PCR amplification (Figure 1E, lane 5). However,egg and early embryo extracts until early blastula
Oct-4 and GCAP expression was strongly upregulatedstage. Late blastula-stage extracts were not only inac-
in 293T spheres treated with egg extract (Figure 1E,tive but also inhibitory to reprogramming. Screening
lanes 1 and 3; summarized in Table S1). In egg extractfor factors required for reprogramming identified the
itself, no Oct-4 or GCAP mRNA was detectable, exclud-chromatin remodeling ATPase BRG1. Antibody deple-
ing amplification of Xenopus orthologs (Figure 1E, lanetion of BRG1 protein or expression of dominant-nega-
6). Surprisingly, while digitonin permeabilization slightlytive BRG1 abolished the reprogramming ability of am-
enhanced Oct-4 upregulation by egg extract, it was notphibian extracts. Conversely, overexpression of BRG1
essential (Figure 1E, lane 3). Concomitant to upregula-in Xenopus animal caps extended their competence
tion of Oct-4 and GCAP, expression of the kidney cellfrom blastula to gastrula stage to respond to basic
marker natriuretic peptide receptor type A (NPR-A) [14]fibroblast growth factor (bFGF) treatment with induc-
was downregulated. Occasionally, samples treatedtion of the mesodermal marker Xbra. Dissection of the
without egg extract showed upregulation of one pluripo-molecular machinery using a simplified assay system
tency marker (data not shown). Oct-4 mRNA expressionmay aid in achieving complete nuclear reprogramming
levels were significantly lower in reprogrammed 293Tof somatic cells for regenerative medicine.
spheres compared to endogenous levels in the human
embryonal carcinoma cell line TERA-1, indicating that
Results and Discussion reprogramming was incomplete, but GCAP mRNA levels
were higher (Figure 1F). However, the upregulation of
Nuclear Reprogramming of Human Cells pluripotency markers suggests that some degree of nu-
Since its initial demonstration in frogs [1], nuclear repro- clear reprogramming toward dedifferentiation has taken
gramming by animal cloning has been demonstrated place.
in sheep [2] as well as in numerous other vertebrates, We next tested whether egg extract was able to re-
proving the reversibility of cell differentiation [3, 4]. Cell program human primary cells. We therefore treated
reprogramming has also been achieved by fusing adult blood leukocytes in an analogous fashion. Rapidly prolif-
thymocytes with murine embryonic stem (ES) cells, re- erating cell clusters became visible at day 2 regardless
sulting in induction of an Oct4-GFP transgene in the of the presence of egg extract and digitonin, and these
heterokaryons [5]. Byrne et al. [6] recently showed that developed into spheres (Figures 1G and 1H). Similar to
Oct-4 was upregulated in somatic nuclei injected into 293T cells, leukocyte spheres expressed low levels of
Xenopus oocytes. These experiments demonstrated endogenous Oct-4 and GCAP mRNAs, which were sig-
that an adult nucleus can be reprogrammed to induce nificantly upregulated in egg extract-treated leukocyte
or upregulate embryonic stem cell markers. We wished spheres (Figure 1I and Table S1). Again, Oct-4 mRNA
to develop a nuclear reprogramming assay that permits upregulation by egg extract was enhanced by digitonin
treatment (Figure 1I, compare lanes 1 and 3), and few
samples treated without egg extract showed upregula-*Correspondence: niehrs@dkfz-heidelberg.de
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Figure 1. Reprogramming of Human Cells by
Xenopus Egg Extract
(A) Diagram of the experiment. Top, prepara-
tion of egg extract; bottom, preparation of
human cells.
(B–D) Morphology of 293T cell spheres devel-
oping after treatment with egg extract and
digitonin. Bars indicate 20 m, 75 m, and
500 m, respectively.
(E) RT-PCR analysis of 293T cell spheres har-
vested at day 6. Co. cells, untreated 293T
cells; extract, cell-free Xenopus egg extract;
H2O, water control. RT-minus controls were
all negative (data not shown).
(F) Comparative RT-PCR analysis of repro-
grammed 293T cell spheres harvested at day
5 and the human embryonal carcinoma cell
line TERA-1. Details are as in (E).
(G and H) Morphology of leukocyte clusters
and spheres after treatment. Bars indicate
200 m and 100 m, respectively.
(I) RT-PCR analysis of human leukocyte
spheres harvested at day 3. Details are as
in (E).
tion of one pluripotency marker (data not shown). Leuko- tion (not shown), we conclude that reprogramming
activity is lost at midblastula transition (MBT), when zy-cyte spheres could be cultured in DMEM for up to 42
gotic transcription begins in Xenopus embryos.days, but they had lost Oct-4 and GCAP upregulation
To identify factors required for reprogramming, we(data not shown). Since leukocytes are a heterogeneous
carried out an immunodepletion screen. Egg extractspopulation, we cannot exclude the possibility that the
were immunodepleted with commercially available anti-results are due to selection of Oct-4/GCAP-positive
bodies against a panel of chromatin regulators and tran-clones. However, together with the effect on 293T cells,
scription factors which appeared as possible candi-the data suggest that transient nuclear reprogramming
dates involved in reprogramming. Immunodepletion ofoccurred.
the chromatin-remodeling ATPase brahma-related gene
1 (BRG1) [15, 16] reproducibly inhibited Oct-4 upregula-
Characterization of Reprogramming tion by egg extract in 293T spheres (Figure 2B, lanes 1
by Embryo Extract and 2, and Table S1). Employing histone core or Oct-4
We tested the competence of extracts prepared from antibody led to the same result (data not shown), but they
different stages of Xenopus embryogenesis to re- were not followed up because the specificity of the
program 293T cells. Upregulation of Oct-4 mRNA ex- antibody was too broad (histone core), or because the
pression was detected with extracts prepared from eggs endogenous protein in Xenopus is unknown (Oct-4). Im-
and fertilized embryos at stage 4 (8 cell) and stage 5 (16 munodepletions of other components of chromatin-
cell) but was lost at late blastula stage 9 (Figure 2A, remodeling complexes were inconclusive (Ini1, BAF 170,
lanes 2–4, and Table S1). Furthermore, when stage 9 CAF-1 p60, CAF-1 p150, p300) or showed no effect (BAF
embryo and egg extracts were mixed 1:4, Oct-4 upregu- 155) (data not shown).
lation was inhibited (Figure 2A, lane 5). Since early blas- Endogenous Xenopus BRG1 protein was detectable
by anti-BRG1 antibody in Xenopus egg extracts, wheretula stage 8 extracts showed only slight Oct-4 upregula-
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Figure 2. Properties of Xenopus Reprogram-
ming Extracts
(A) Dependency of embryo extract repro-
gramming capacity on developmental stage.
Eggs or embryos of the indicated stages were
harvested, and extract was prepared and
tested for reprogramming as described in
Figure 1. A RT-PCR analysis of 293T cell
spheres, harvested at day 5 and treated as
indicated, was performed.
(B) BRG1 is required for reprogramming.
Schematic diagram of the experiment is
shown. Egg extract (“Extract”) was immuno-
depleted with anti-BRG1 antibody and sup-
plemented with 5% or 10% rescue extract
as indicated (, ). Rescue extracts were
prepared from stage 7 embryos that had been
injected with 1 ng of either GFP or BRG1
mRNA into both blastomeres at the two-cell
stage (“BRG1 extract,” “GFP extract”). The
reconstituted extracts were tested in a stan-
dard reprogramming experiment with digito-
nin in 293T cells. Lane 5, cells treated with
egg extract only; lane 6, cells treated with
egg extract that had been mock depleted by
uncoated beads.
(C) Western blot of HeLa nuclear extract (10
g) and Xenopus egg extract (26 g) probed
with anti-BRG1 (1:200 dilution).
(D) Blocked reprogramming by dominant-
negative BRG1 can be rescued with wild-type
BRG1. Extracts were prepared as described
in (B) from embryos injected with 2 ng of dn
BRG1, BRG1, or GFP mRNA. Embryo extracts
were tested in a standard reprogramming ex-
periment with digitonin in 293T cells.
it recognizes an expected 200 kDa band, as it does in reprogramming may require supraphysiological amounts
of BRG1. However, the rescue effect was more pro-human HeLa cells (Figure 2C). This confirms an earlier
report showing that Xenopus BRG1 protein is present nounced when less BRG1-injected embryo extract was
used (compare lanes 3 and 4), suggesting that too-highin oocytes, eggs, and embryos at various stages [17].
To test if inhibition of reprogramming was indeed due amounts of BRG1 may also be inhibitory. Alternatively,
Xenopus- and 293T-BRG1 may differ in their functionalto BRG1 depletion, a rescue experiment was carried out
(Figure 2B, top). Oct-4 upregulation was reconstituted states.
To corroborate the role of BRG1, reprogramming ofin BRG1-immunodepleted extracts only when they were
supplemented with extracts from early embryos injected 293T cells was carried out with extracts from early em-
bryos injected with a dominant-negative (dn) form ofwith BRG1 mRNA but not with GFP mRNA (Figure 2B,
lanes 1–4, and Table S1). Since nonreprogrammed 293T BRG1 [18] or coinjected with wild-type and dn BRG1
mRNA. While dn BRG1 inhibited Oct-4 upregulation,cell nuclei already harbor endogenous BRG1 protein [7],
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Xbra induction even at gastrula stage (Figure 3C, lanes
3–6, and Table S1). Xbra mRNA induction at gastrula
stage still required bFGF treatment, and BRG1 overex-
pression alone was ineffective. In animal caps that were
bFGF treated at blastula stage, BRG1 and dn BRG1 had
minor enhancing and inhibiting effects on Xbra induc-
tion, respectively. Morphology of BRG1- and dn BRG1-
injected embryos was normal in all cases at stages 8.5
and 10.5, and no delay of development was visible. We
conclude that BRG1 extends the competence period of
animal cap cells to differentiate into mesoderm. This
suggests that BRG1 overexpression can prolong the
pluripotency of embryonic cells in Xenopus.
In this study, we have demonstrated that intact adult
human cells can be reprogrammed to upregulate embry-
onic stem cell markers. The in vitro system we developed
allows for the study of reprogrammed cells as well as
the reprogramming extract. The fact that digitonin treat-
ment is in principle dispensable during reprogramming
suggests that the necessary factors can (also) enter the
cells by an endocytic route. However, the leukocyte
reprogramming achieved by our protocol was clearly
incomplete: upregulation of Oct-4 and GCAP was tran-
sient and lost after prolonged culture, characteristic
pluripotency-associated cell surface markers such as
SSEA-3, -4, Tra-1-60, and Tra-1-81 were not detectable,
and permanent cell lines could not be established (data
not shown). Furthermore, leukocyte clusters and spheres
failed to grow when transplanted in nude mice (data not
shown). General intra- and interexperimental variabilityFigure 3. BRG1 Extends the Competence for Mesoderm Induction
of reprogramming success as reported by Byrne and(A) shows a schematic representation of animal cap (AC) assay.
colleagues [6] was confirmed in our system (see TableFour-cell Xenopus embryos were injected or noninjected into the
animal pole of each blastomere with 0.75 ng BRG1 mRNA per blasto- S1). More refined reprogramming protocols may allow
mere or 0.25 ng dn BRG1 mRNA per blastomere. ACs were explanted the full equivalent of ES cells to be obtained in the future.
at stage 8.5 (B) or at stage 10.5 (C) and treated or nontreated with Nevertheless, the protocol allowed us to characterize
100 ng/ml (stage 8.5) or 200 ng/ml bFGF (stage 10.5) for 3 hr. At the
cell extracts, and we showed that reprogramming ca-equivalent of stage 12, animal caps were harvested and analyzed
pacity is not limited to eggs but extends to fertilizedby RT-PCR. None, noninjected ACs; WE, whole embryo.
embryos until the MBT. The fact that post-MBT extract
dominantly inhibited reprogramming by egg extract sug-
coexpression with wild-type BRG1 rescued this effect gests that zygotic transcription may activate genes
(Figure 2D, lanes 2 and 3, and Table S1). However, injec- which repress the pluripotent cell state. This is consis-
tion of wild-type or dn mRNA of the related chromatin- tent with the gradual loss of competence of Xenopus
remodeling ATPase brahma (BRM) [16, 19, 20] showed cells to contribute to all three germ layers [23].
no effect on Oct-4 expression (data not shown). Taken Importantly, our protocol allowed us to identify BRG1
together, the results indicate that the chromatin remod- as a component required for reprogramming by Xeno-
eler BRG1 is required during reprogramming of 293T pus egg extracts. BRG1 is a homolog of the yeast SWI2/
cells by egg extract. SNF2 and the Drosophila brahma genes [15]. Together
To further study the role of BRG1 in the maintenance with BRM, it constitutes the two ATPase subunits of the
of pluripotency, we investigated the process of Xenopus human SWI-SNF chromatin-remodeling complex [16].
mesoderm induction. Dissected Xenopus animal caps SWI-SNF is involved in remodeling of nucleosomes as
can be induced by growth factors such as bFGF to well as in transfer of histones and acts by increasing
form mesoderm up until the late blastula stage [21]. DNA access (for review see [24]). We show that BRG1
Afterwards, the competence of animal caps for meso- is not only required for upregulation of Oct-4, but that
derm induction gradually decreases because cells loose it can extend the competence period to form mesoderm
their pluripotency and differentiate into ectoderm [22]. in Xenopus animal cap explants. This finding points to
We therefore tested if forced BRG1 expression by mRNA an important role of chromatin remodeling for both in-
injection might promote pluripotency in animal cap cells duction and maintenance of pluripotency during repro-
(Figure 3A). As expected, animal caps induced with gramming and early embryogensis. Indeed, homozy-
bFGF expressed the mesodermal marker Xenopus gous BRG1 mutant mice die during the periimplantation
brachyury (Xbra) only when they were treated at blastula stage [25].
(stage 8.5) but not at gastrula stage (stage 10.5) (Figures Interestingly, another chromatin-remodeling ATPase,
3B and 3C, lanes 1 and 2). However, expression of BRG1 ISWI-D, has also been implicated in nuclear reprogram-
ming [26]. ISWI-D is a member of the ISWI remodelingbut not dn BRG1 rendered animal caps permissive for
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ugation for 20 min at 2000 rpm, the purified buffy coat layer con-complex, which is distinct from the SWI-SNF complex.
taining leukocytes was harvested, transferred to a new 50 ml FalconISWI-D is required for the specific release of TATA bind-
tube, diluted with PBS up to 50 ml, and recentrifuged for 10 min ating factor from adult nuclei incubated with Xenopus
1500 rpm. Cells were resuspended in 1 ml ice-cold transport buffer,
oocyte extracts, which accompanies chromatin decon- and 0.5 ml was used per reprogramming experiment.
densation and protein exchange. ATPase-dependent re- For reprogramming, cells were pelleted and resuspended in 0.5
ml transport buffer 35g/ml digitonin (Calbiochem) and incubatedmodeling may thus act in concert with traditional tran-
for 5 min on ice. Cells were washed in transport buffer, resuspendedscriptional regulators such as Oct-4 [9] and Nanog [27,
in 20 l reprogramming mix (1 l 20 mg/ml BSA [Roche, Mannheim,28] to achieve pluripotency in mammals.
Germany], 1 l 20 mM ATP, 1 l 100 mM phosphocreatine, 1 l 400
U/ml creatine kinase [all Sigma], 1 l RNAsin [40 U/l; Promega,Experimental Procedures
Madison, WI], 5 l transport buffer, 10 l egg or embryo extract)
and incubated for 30 min at 37C. Incubation was terminated byXenopus laevis Egg Extract
addition of 0.5 ml ice-cold transport buffer. 293T cells and leuko-Xenopus laevis egg and embryo extracts were essentially prepared
cytes were centrifuged, resuspended in cell culture medium, andas described [29]. Eggs were obtained by priming females with
cultivated in 4 cm petri dishes (Renner, Dannstadt, Germany) at600 IU human chorionic gonadotropin and were dejellied with 2%
37C with 10% CO2. For the standard assay, spheres were harvestedcysteine HCl. In vitro fertilizations were carried out as described [30].
at day 6 (day 1  experiment).Eggs and embryos were washed two times with ice-cold extraction
buffer (50 mM HEPES/KOH [pH 7.4], 50 mM KCl, 5 mM MgCl2, 2
RT-PCRmM -mercaptoethanol, 5 mM EGTA, second wash including 10
RT-PCR for Xenopus animal cap assays was carried out as de-g/ml each cytochalasin B [Sigma, Munich, Germany], leupeptin,
scribed [30]. RT-PCR of human cells was carried out as follows.aprotinin, pepstatin A [all Calbiochem Biosciences, La Jolla, CA]).
RNA was essentially prepared as described [32]. Spheres, clusters,Eggs or embryos were centrifuged at 1000 rpm for 1 min and trans-
and cells were harvested by glass needle aspiration and transferredferred to 2 ml Eppendorf tubes after excessive buffer was carefully
to 100 l denaturing solution (4 M GnSCN, 0.5% sarcosinate, 1%removed. Eggs and embryos were crushed by centrifugation at
-mercaptoethanol, 20 g rRNA), laid over 100 l 5.7 M CsCl, and10,000  g for 15 min at 4C. The middle layer was collected and
spun for 3.5 hr at 174,000  g in a TL-100 Tabletop Ultracentrifugerecentrifuged at 16,000  g to clear the extract. The extract was
(Beckman Coulter, Fullerton, CA) using a TLA 100.2 rotor. The super-substituted with 2% glycerol, and aliquots were snap frozen in liquid
natant was discarded in several steps with new pipette tips to care-nitrogen and stored at 80C.
fully avoid DNA contamination. The RNA pellet was washed in 70%
EtOH, dried, resuspended in 20 l DEPC-H2O, and reprecipitatedRNA Injection and Animal Cap Assay
with sodium acetate. The washed and dried pellet was resuspendedMicroinjection of mRNAs as well as Xenopus embryo and explant
in 1.3 l DEPC-H2O, and 0.18 l 10 reaction buffer and 0.3 lculture were performed as previously described [30]. Synthetic
DNase I (Invitrogen Life Technologies, Carlsbad, CA) were addedmRNA of human BRG1, dn BRG1 [18], and enhanced green fluores-
and incubated for 15 min at room temperature. DNase digestion wascent protein (eGFP; Clontech, Palo Alto, CA) were in vitro transcribed
stopped by addition of 0.18 l 25 mM EDTA and heat inactivation atusing the MegaScript kit (Ambion, Austin, TX) according to the man-
65C for 15 min.ufacturer’s instructions. Animal caps were dissected at stages 8.5
For reverse transcription, 4 l random hexamers (50 ng/l; In-or 10.5 and incubated with 100 or 200 ng/ml bFGF (Sigma) for 2–3
vitrogen) was added to the DNase-treated RNA solution, incubatedhr and harvested at stage 12 for RT-PCR analysis.
at 70C for 10 min, and placed on ice. 1 l 10 PCR buffer, 1 l 25
mM MgCl2, 0.5 l 10 mM dNTP, 1 l 0.1 M DTT, and 0.1 l RNAsinImmunodepletion
(Promega) were added and incubated at 25C for 5 min. 1.9 l ofProtein A- or protein G-coupled Dynabeads in 10 l suspension
the sample was removed for RT-negative reactions; to the rest, 0.4(Dynal, Hamburg, Germany) were washed four times with 1 TBS 
l (80 U) Superscript II RT (Invitrogen) was added and incubated at0.1% BSA (washing solution) in 0.2 ml Eppendorf tubes using a
25C for 10 min and at 42C for 50 min. The reaction was terminatedmagnet. Beads were precharged with 25 g anti-BRG1 N-15 anti-
by heating to 95C for 5 min.body (Santa Cruz Biotechnology, Heidelberg, Germany) by incubat-
PCR reactions for human cells were carried out with 0.1l (1:10ing for 2 hr at room temperature with agitation. Unbound antibody
diluted) to 3 l (undiluted) RT reactions. Primers were Oct-4 (basedwas washed away with washing solution, and beads were resus-
on [33]; 5	-GACAACAATGAAAATCTTCAGGAGA, 3	-TTCTGGCGCCpended in 3 l washing solution and stored at 4C. For immunode-
GGTTACAGAACCA; 218 bp product) and -actin (5	-CGTGGGGCGpletion, 1 l beads was washed once again in washing solution,
CCCCAGGCACCA, 3	-TTGGCCTTGGGGTTCAGGGGGG; 243 bpand 10 l egg extract was added and incubated for 1 hr at 4C with
product); other primers were described: GCAP [34] (484 bp product),agitation. Beads were removed by magnet, and the supernatant
NPR-A [35] (491 bp product), Xbra [30] (324 bp product), histone 4was used for reprogramming without delay. For control experiments,
(H4) [30] (188 bp product). For all RT-PCR experiments, the samplesuncoupled beads were used. For rescue experiments, 9 or 9.5 l
were first analyzed for -actin or H4 mRNA expression, and templateimmunodepleted extract was supplemented with 0.5 or 1 l of GFP
concentrations were then adjusted accordingly to obtain normalizedor BRG1 mRNA-injected embryo (stage 7) extract. For Western blot
samples. In the final PCRs, the same number of cycles for all samplesanalysis, anti-BRG1 P18 antibody (Santa Cruz Biotechnology) was
was used for each gene and experiment so that results are compara-used.
ble. PCR cycles for Oct-4 were 36–42; GCAP, 44; NPR-A, 41; Xbra,
26–36; -actin, 24–30; and H4, 24. Control reactions included RT-Reprogramming with Xenopus Extracts
negative, H2O, media, and egg extract samples.293T cells were grown to subconfluency in cell culture medium
(DMEM) (Cambrex Bio Sciences Verviers, Verviers, Belgium), 10%
Supplemental DataFCS (PAA Laboratories, Linz, Austria), 1% glutamine (Cambrex Bio
Supplemental Table S1 is available at http://www.current-biology.Sciences Verviers) and incubated in 10% CO2. Cells (4  106 per
com/cgi/content/full/14/16/1475/DC1.reprogramming experiment) were harvested by flushing with PBS
and transferred to 15 ml Falcon tubes. Cells were pelleted and
resuspended in 0.5 ml ice-cold transport buffer (based on [31]; 20 Acknowledgments
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